FIGURE 2. (A) ¹³¹I-MIBG imaging of patient 18 during radionuclide therapy shows high uptake in multiple liver metastases and primary site. (B) Fifteen months later, ¹²³I-MIBG imaging shows partial remission, with only faint uptake in primary site.